| CYHS2301225 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(4) | Generic Drug | 2023-05-06 | | | | | view |
| CYHS2101455 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(4) | Generic Drug | 2021-07-21 | | | | | view |
| CYHS2402636 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(4) | Generic Drug | 2024-08-14 | | Hainan Brilliant Pharmaceutical Co Ltd | | | view |
| JYHZ2300385 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(5.1) | License Renew | 2023-09-19 | | | | | view |
| CYHS2300657 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(4) | Generic Drug | 2023-02-28 | | | | | view |
| CYHS2302300 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(4) | Generic Drug | 2023-08-30 | | Zhejiang Hsing Pharmaceuticals Co Ltd | | | view |
| CYHS2300480 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(4) | Generic Drug | 2023-02-11 | | Zhejiang Hsing Pharmaceuticals Co Ltd | | | view |
| CYHS2302221 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(4) | Generic Drug | 2023-08-22 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| JYHB2200607 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(5.1) | Supplementary Application | 2022-11-04 | | | | | view |
| JYHB2400527 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(5.1) | Supplementary Application | 2024-10-10 | | | | | view |
| JXHL1100074 | 甲磺酸艾日布林注射液 | eribulin mesylate | Injection | Chemical Drugs | Import Drug Application | 2011-04-22 | Eisai Inc. | Eisai Inc | Certificate Issued | 2013-04-11 | view |
| JXHL0800257 | E7389（Eribulin mesylate Injection） | eribulin mesylate | Injection | Chemical Drugs | Import Drug Application | 2008-08-13 | Eisai Limited | Eisai Ltd | Certificate Issued | 2009-04-08 | view |
| JYHB1901121 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs | Supplementary Application | 2019-09-07 | 卫材（中国）药业有限公司 | Eisai China Inc | Filed | 2019-09-18 | view |
| JYHB2002287 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(5.1) | Supplementary Application | 2020-11-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2020-11-11 | view |
| JXHS1700048 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(5.1) | Import Drug Application | 2017-12-06 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2019-07-16 | view |
| JYHB2001103 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs | Supplementary Application | 2020-06-28 | 卫材（中国）药业有限公司 | Eisai China Inc | Filed | 2020-06-30 | view |
| JXHS1600052 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs(5.1) | Import Drug Application | 2016-08-15 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2017-06-21 | view |
| JYHB1901122 | 甲磺酸艾立布林注射液 | eribulin mesylate | Injection | Chemical Drugs | Supplementary Application | 2019-09-07 | 卫材（中国）药业有限公司 | Eisai China Inc | Filed | 2019-09-18 | view |
